San Diego-based Anadys Pharmaceuticals says its CEO is stepping down to take a job at a venture capital company. Kleanthis Xanthopoulos is joining Enterprise Partners as a managing partner. Xanthopoulos will stay on as a board member. Anadys inked a deal with Novartis last year to develop the hepatitis C therapy ANA975. Report